WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013

Jul 2, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-06-28

Reporting Person: BUTHMAN MARK A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-06-28	Phantom Stock Unit	$	A	301.7600	Acquired		Common Stock (301.7600)	Direct

Footnotes

F1: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

F2: Reflects additional Phantom Stock Units credited through dividend reinvestment based on most recent plan statement.